The protease inhibitor ritonavir inhibits the functional activity of the multidrug resistance related-protein 1 (MRP-1)

Douglas P. Olson, David T. Scadden, Richard T. D’Aquila, Maria Pia De Pasquale

AIDS · 2002 · 81 citations · 18 references

Abstract

These data may be exploitable to further improve sanctuary site concentrations of anti-HIV or anti-cancer drugs by using ritonavir as a lead compound to develop more potent MRP-1 inhibitors.

References

18